Lymphoblastic (diffuse) lymphoma, lymph nodes mult site is a type of aggressive non-Hodgkin lymphoma characterized by the proliferation of immature lymphoid cells. This condition primarily affects lymph nodes in multiple sites and is associated with significant clinical implications, including rapid disease progression and potential for systemic involvement. Accurate coding with ICD-10 Code C83.58 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this serious condition.
ICD-10 Code C83.58 represents Lymphoblastic (diffuse) lymphoma, lymph nodes mult site, a hematological malignancy characterized by the presence of lymphoblasts in multiple lymph node regions. This code is used in clinical documentation and billing when diagnosing patients with this aggressive form of lymphoma, which requires prompt intervention and management due to its rapid progression and potential complications.
Lymphoblastic (diffuse) lymphoma, lymph nodes mult site is primarily caused by genetic mutations leading to uncontrolled proliferation of lymphoblasts. The condition can progress rapidly, necessitating immediate medical attention to prevent severe complications. Early diagnosis and treatment are crucial for improving patient outcomes.
ICD-10 Code C83.58 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. This code is relevant in both acute and chronic care settings, facilitating accurate communication among healthcare providers and ensuring comprehensive patient management.
In SOAP notes, ICD-10 Code C83.58 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Lymphoblastic (diffuse) lymphoma, lymph nodes mult site. This ensures continuity of care, supports appropriate billing, and meets EHR documentation standards.
The management of Lymphoblastic (diffuse) lymphoma, lymph nodes mult site often requires hospitalization due to the aggressive nature of the disease. Treatment typically involves chemotherapy and may include supportive care measures.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C83.58 is critical in medical billing, particularly in hospital and emergency room settings, where accurate coding is essential for reimbursement.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 96415 | Chemotherapy administration, intravenous, infusion technique. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
Common Questions About Using ICD-10 Code C83.58 for Lymphoblastic (diffuse) lymphoma, lymph nodes mult site
What are the common symptoms of Lymphoblastic lymphoma?
Common symptoms include swollen lymph nodes, fever, night sweats, and unexplained weight loss. Patients may also experience fatigue and bone pain due to bone marrow involvement.
How is Lymphoblastic lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes to confirm the presence of lymphoblasts.
What is the treatment for Lymphoblastic lymphoma?
Treatment usually consists of intensive chemotherapy regimens, and in some cases, hematopoietic stem cell transplantation may be considered for eligible patients.
Is Lymphoblastic lymphoma common in children?
Yes, Lymphoblastic lymphoma is more prevalent in children and young adults, particularly males, and is considered a type of aggressive non-Hodgkin lymphoma.
Clinical Notes
SOAP notes
DAP notes
AI medical notes